We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-9.54%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$455M
AUM Growth
-$72.3M
Cap. Flow
-$12.5M
Cap. Flow %
-2.74%
Top 10 Hldgs %
51.9%
Holding
94
New
10
Increased
20
Reduced
27
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 20.49%
2 Consumer Discretionary 19.55%
3 Financials 13.18%
4 Real Estate 9.6%
5 Technology 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXLG icon
26
Destination XL Group
DXLG
$31.2M
$4.88M 1.07%
900,000
CUBI icon
27
Customers Bancorp
CUBI
$2.66B
$4.42M 0.97%
150,000
TLYS icon
28
Tilly's
TLYS
$116M
$3.95M 0.87%
571,150
-48,850
-8% -$371K
ASTL icon
29
Algoma Steel
ASTL
$406M
$3.81M 0.84%
590,899
-909,101
-61% -$8.12M
SFIX
30
Stitch Fix
SFIX
$536M
$3.67M 0.81%
929,200
+104,200
+13% +$592K
PHAT icon
31
Phathom Pharmaceuticals
PHAT
$708M
$3.5M 0.77%
315,975
+60,208
+24% +$574K
FLWS icon
32
1-800-Flowers.com
FLWS
$250M
$3.28M 0.72%
+505,900
New +$4.48M
QURE icon
33
uniQure
QURE
$3.03B
$3.28M 0.72%
175,000
-97,091
-36% -$2.04M
NXDT
34
NexPoint Diversified Real Estate Trust
NXDT
$234M
$3.14M 0.69%
250,000
GBTG icon
35
American Express Global Business Travel
GBTG
$4.93B
$2.92M 0.64%
515,400
+270,192
+110% +$1.81M
ILPT
36
Industrial Logistics Properties Trust
ILPT
$575M
$2.75M 0.6%
+500,000
New +$4.52M
IVAC
37
DELISTED
Intevac Inc
IVAC
$2.42M 0.53%
520,000
+15,965
+3% +$77.3K
WVE icon
38
Wave Life Sciences
WVE
$1.09B
$2.17M 0.48%
600,000
+196,447
+49% +$650K
DNMR
39
DELISTED
Danimer Scientific, Inc.
DNMR
$1.84M 0.4%
15,625
ETNB
40
DELISTED
89bio
ETNB
$1.79M 0.39%
310,000
COLL icon
41
Collegium Pharmaceutical
COLL
$1.15B
$1.68M 0.37%
105,000
PYXS icon
42
Pyxis Oncology
PYXS
$168M
$1.58M 0.35%
800,000
ATAI icon
43
AtaiBeckley Inc
ATAI
$2.66B
$1.56M 0.34%
470,000
CIX icon
44
Comp X International
CIX
$349M
$1.51M 0.33%
93,160
-6,840
-7% -$152K
ALR
45
DELISTED
AlerisLife Inc
ALR
$1.43M 0.31%
1,500,000
CYT
46
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$1.26M 0.28%
654,112
+47,864
+8% +$125K
CTMX icon
47
CytomX Therapeutics
CTMX
$675M
$1.16M 0.25%
800,000
-273,400
-25% -$421K
OLMA icon
48
Olema Pharmaceuticals
OLMA
$1B
$1.1M 0.24%
400,000
-100,000
-20% -$424K
ALGS icon
49
Aligos Therapeutics
ALGS
$26.2M
$1.1M 0.24%
40,000
+1,516
+4% +$50.3K
IVVD icon
50
Invivyd
IVVD
$158M
$1.1M 0.24%
350,000
-50,875
-13% -$203K

Similar funds

Newtyn Management's Q3 2022 Portfolio in Review

As of Q3 2022, Newtyn Management held 94 positions worth $455M, down 14% from $528M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Newtyn Management's Q3 2022 filing shows 10 new, 20 increased, 27 reduced and 14 closed positions. Its largest new stake was Sylvamo: 438,674 shares worth $14.9M. The largest sale was Epizyme, Inc, an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Newtyn Management's largest Q3 2022 buy was Sylvamo: 438,674 shares worth $14.9M.
  • Newtyn Management added most to People Inc in Q3 2022, an estimated $6.86M increase.
  • Newtyn Management's biggest Q3 2022 reduction was Algoma Steel, cutting an estimated $8.12M.
  • Newtyn Management fully exited Epizyme, Inc in Q3 2022, selling an estimated $11.1M.
  • Newtyn Management's ten largest holdings make up 52% of its $455M portfolio in Q3 2022.
  • Newtyn Management opened 10 new positions and closed 14 in Q3 2022.
  • Newtyn Management's portfolio value fell 14% quarter-over-quarter to $455M.

Based on Newtyn Management's 13F filing for Q3 2022, filed 14 Nov 2022.